Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-NOTA-RF PET in Pituitary Adenomas
NCT07254104Phase 1Enrolling by invitation
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2025
- Primary completion
- Oct 2026
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-NOTA-RF in pituitary adenoma, sponsored by Peking Union Medical College Hospital. Primary endpoint: Maximum Standardized Uptake Value. Started Nov 2025; status: enrolling by invitation.
02
Drugs
68Ga-NOTA-RF
03
Conditions
pituitary adenoma
Beyond the preview
Go deeper on NCT07254104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07254104.